2015, Número 2
<< Anterior
Rev Mex Pediatr 2015; 82 (2)
Manejo por drogas adictivas y tóxicos letales en Pediatría
Pinacho-Velázquez JL
Idioma: Español
Referencias bibliográficas: 39
Paginas: 71-79
Archivo PDF: 224.80 Kb.
RESUMEN
Los adolescentes y adultos jóvenes representan el grupo más vulnerable en el mercado de estimulantes: desde los cigarros hasta las metanfetaminas. En los últimos 10 años se ha incrementado el número de personas que acuden a los servicios de salud con antecedente de intoxicación o abuso de drogas adictivas o de tóxicos letales. En este artículo de revisión se describen las características de este tipo de pacientes, así como la forma de manejarlos.
REFERENCIAS (EN ESTE ARTÍCULO)
Hazinsky MF. Toxicology. In: Hazinsky MF, editor. PALS Provider Manual. Salem, Oregon, EUA: American Heart Association and American Academy of Paediatrics; 2012. pp. 305-319.
Encuesta Nacional de Adicciones del 2011. Disponible en: www.conacid.salud.gob.mx/pdfs/ENA_2011_drogas_ilicitas_.pdf
Beebe DK, Walley E. Smokable methamphetamine (“ice”): an old drug in a different form. Am Fam Physician. 1995; 51: 449-453.
Callaway CW, Clark RF. Hyperthermia in psychostimulant overdose. Ann Emerg Med. 1994; 24: 68-76.
Jones AL, Jarvie DR, McDermid G, Proudfoot AT. Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol. 1994; 32: 435-444.
Jorens PG, Heytens L, Demey HE, Andries S, Ricaurte GA, Bossaert L et al. Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs. Intensive Care Med. 1996; 22: 456-459.
Mithoefer M, Jerome L, Doblin R. MDMA “ectasy” and neurotoxicity. Science. 2003; 300: 1504-1505.
National Institute on Drug abuse, metanfetamina 2005, Available in: http://www.nida.nih.gov/infofacts/Methamphetamine-Sp.html
Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Association between life-threatening cocaine toxicity and plasmacholinesterase activity. Ann Emerg Med. 1992; 21: 247-253.
Hoffman RS, Morasco R, Goldfrank LR. Administration of purified humanplasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol. 1996; 34: 259-266.
Marcovigi P, Leoni S, Calbi G, Valtancoli E, Granata A, Gudenzi P et al. Acute cocaine poisoning in a body packer. Minerva Anestesiol. 1995; 61: 109-112.
Aldrighetti L, Graci C, Paganelli M, Vercesi M, Catena M, Ferla G. Intestinal occlusion in cocaine-packet ingestion. Minerva Chir. 1993; 48: 1233-1237.
Mueller PD, Benowitz NL, Olson KR. Cocaine. Emerg Med Clin North Am. 1990; 8: 481-493.
Katz AA, Hoffman RS, Silverman RA. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med. 1993; 22: 1485-1487.
Nogue S, Sanz P, Munne P, de la Torre R. Acute scopolamine poisoning after sniffing adulterated cocaine. Drug Alcohol Depend. 1991; 27: 115-116.
Insley BM, Grufferman S, Ayliffe HE. Thallium poisoning in cocaine abusers. Am J Emerg Med. 1986; 4: 545-548.
Stevens DC, Campbell JP, Carter JE, Watson WA. Acid-base abnormalities associated with cocaine toxicity in emergency department patients. J Toxicol Clin Toxicol. 1994; 32: 31-39.
López MG. El niño intoxicado. En: Menabrito TJ. Urgencias. Temas de Pediatría Asociación Mexicana de Pediatría. McGraw Hill Interamericana México 1997. pp. 135-159.
Lange RA, Cigarroa RG, Yancy CW, Willard JE, Popma JJ, Sills MN, et al. Cocain-induced coronary-artery vasoconstriction. N Eng J Med. 1989; 321: 1557-1562.
Instituto Nacional de Abuso de Drogas. Serie de reportes de investigación Cocaína abuso y adicción 2005. Disponible en: http://www.drugabuse.gov/ResearchReports/Cocaina/Cocaina.html
Farrar HC, James LP, Characteristics of pediatrics admissions for cyclic antidepressant poisoning. Am J Emerg Med. 1999; 17: 495-496.
Hulten BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand. 1982; 213: 275-279.
Rosenbaum TG, Kou M. Are one or two dangerous? Tricyclic antidepressant exposure in toddlers. J Emerg Med. 2005; 28: 169-174.
Seger DL, Hantsch C, Zavoral T, Wrenn K. Variability of recommendations for serum alkalinization in tricyclic antidepressant overdose: a survey of U.S. Poison Center medical directors. J Toxicol Clin Toxicol. 2003; 41: 331-338.
Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev. 2005; 24: 205-214.
Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci. 1995; 310: 258-263.
Goldfrank’s L. Toxicologic emergencies. Seventh ed., Editorial McGraw-Hill. 2002.
Brayer AF, Wax P. Accidental ingestion of sustained release calcium channel blockers in children. Vet Hum Toxicol. 1998; 40: 104-106.
Ioulios P, Charalampos M, Efrossini T. The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms. Dermatol Online J. 2003; 9: 6.
Katz AM. Calcium channel diversity in the cardiovascular system. J Am Coll Cardiol. 1996; 28: 522-529.
Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci. 1995; 310: 258-263.
Barrow PM, Houston PL, Wong DT. Overdose of sustained-release verapamil. Br J Anaesth. 1994; 72: 361-365.
Belson MG, Gorman SE, Sullivan K, Geller RJ. Calcium channel blocker ingestions in children. Am J Emerg Med. 2000; 18: 581-586.
Taboulet P, Cariou A, Berdeaux A, Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. J Toxicol Clin Toxicol. 1993; 31: 531-551.
DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004; 23: 223-238.
Love JN. Beta-blocker toxicity: a clinical diagnosis. Am J Emerg Med. 1994; 12: 356-357.
Love JN1, Howell JM, Litovitz TL, Klein-Schwartz W. Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol. 2000; 38: 275-281.
Love JN1, Litovitz TL, Howell JM, Clancy C.Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. J Toxicol Clin Toxicol. 1997; 35: 353-359.
Mégarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev. 2004; 23: 215-222.